{"id":409924,"date":"2021-01-06T16:34:19","date_gmt":"2021-01-06T21:34:19","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=409924"},"modified":"2021-01-06T16:34:19","modified_gmt":"2021-01-06T21:34:19","slug":"vtv-therapeutics-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-virtually","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/vtv-therapeutics-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-virtually\/","title":{"rendered":"vTv Therapeutics to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event Virtually"},"content":{"rendered":"<div class=\"mw_release\">\n<p>HIGH POINT, N.C., Jan.  06, 2021  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Mu1bjdlMqtPawxIgOFXrB-oARJea7zJopJDzvrZMmQcyzO_Z_1kLaSsbD_FPqJnMABxw0NgX0S0tLzNU3xYRY4rRRQhJKEq_rF7PciE-j6Y=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>vTv Therapeutics Inc.<\/u><\/a>\u00a0(Nasdaq: VTVT) a clinical-stage biopharmaceutical company focused on the development of orally administered treatments for type 1 diabetes and inflammatory diseases, today announced that it is participating in the LifeSci Partners 10<sup>th<\/sup> Annual Healthcare Corporate Access Event held virtually from January 11-14 2021.<\/p>\n<p>Company management will be conducting one-on-one virtual meetings during the week of the conference concurrently with J.P. Morgan\u2019s 39th\u00a0Annual Healthcare Conference. To request a meeting, please visit the following registration link <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CZZWujLPXD0XQR2qMOV29xwRft-93WuiWKcSg-Eb7bXML7RkG7RmfU-ddgQL13TLkRkU3O-NGFnW-arEE6XLEQfXF3b2nNEB8-bd-JbYsSipuklsrTmQwei7VE0gW1D-Eoxybq0LdHGzzPcGYVqlHUkW1Xrr0IUZKz_5s7lI9rjFCZlY7eRiiChZkXreU9hS4xatPJEo2a4wfKdEYO25fCzDG6fheU46UL7a0Y0mFM97fRJrvFqVmBr-jP6mSmCXGCkVt2Me6CUfj49pRbsNhDz9zTomn3_-SahP33EUa6Bqy8fH2x51DshaYEY0rCCoHarxa83VgZdlsQFdMj3MXDzm7PbmZpRgjEMvqlYRsb8HHca88cq4jMY7O4VXK8B0Ovzxa7cj7LCIHfqv5KJdkvvF9c-oAuL9QOmbD_3VVIlveoTbJxh7MEH6CDt3uAWp_pC326ABs-NayZ3ql9RaY2Mgnjo6WVF10o3i4MJZ2gCKcbfldEPKUDsW3_oz-uHPb0OcJ7tX78dzXgavbGHK3Bs5D3FxkqPdDAh1auh9hqKIcx_p7Cfosk9Z1htG2-KTzhnZrbtaxs5Mm6sUCXTF8vgYpp9nRTMMxLLONFqcN6Q=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">http:\/\/lifesci.events\/LifeSci2021<\/a>.<\/p>\n<p>\n        <strong>About\u00a0vTv Therapeutics<\/strong><br \/>\n        <br \/>vTv Therapeutics Inc.\u00a0is a clinical-stage biopharmaceutical company focused on developing oral small molecule drug candidates. vTv has a pipeline of clinical drug candidates led by programs for the treatment of type 1 diabetes and inflammatory disorders. vTv\u2019s development partners are pursuing additional indications in type 2 diabetes, chronic obstructive pulmonary disease (COPD), renal disease and genetic mitochondrial diseases. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FBu0lAL2sJuULwXj_gDHoAIccEBnPG-70RnuBGE74_71PfsO6eC7UxUIE22H9eYuRzVQHryGtX6HLDJWyWKUQc5sl8b1AxXku6nuOHvLKvQ=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.vtvtherapeutics.com<\/a>\u00a0or follow us on Twitter: @vTvTherapeutics.<\/p>\n<p>\n        <strong>Forward-Looking Statements<\/strong><br \/>\n        <br \/>This release contains forward-looking statements, which involve risks and uncertainties. These forward-looking statements can be identified by the use of forward-looking terminology, including the terms \u201canticipate,\u201d \u201cbelieve,\u201d \u201ccould,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201cmay,\u201d \u201cplan,\u201d \u201cpotential,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201cshould,\u201d \u201ctarget,\u201d \u201cwill,\u201d \u201cwould\u201d and, in each case, their negative or other various or comparable terminology. All statements other than statements of historical facts contained in this release, including statements regarding the timing of our clinical trials, our strategy, future operations, future financial position, future revenue, projected costs, prospects, plans, objectives of management and expected market growth are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Important factors that could cause our results to vary from expectations include those described under the heading \u201cRisk Factors\u201d in our Annual Report on Form 10-K and our other filings with the\u00a0SEC. These forward-looking statements reflect our views with respect to future events as of the date of this release and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. These forward-looking statements represent our estimates and assumptions only as of the date of this release and, except as required by law, we undertake no obligation to update or review publicly any forward-looking statements, whether as a result of new information, future events or otherwise after the date of this release. We anticipate that subsequent events and developments will cause our views to change. Our forward-looking statements do not reflect the potential impact of any future acquisitions, merger, dispositions, joint ventures or investments we may undertake. We qualify all of our forward-looking statements by these cautionary statements.<\/p>\n<p>\n        <strong>Contacts<\/strong>\n      <\/p>\n<p>Investors:<\/p>\n<p>Corey Davis<br \/>LifeSci Advisors<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=D3fcn1jvW9nj7JZcKh0nK-HVQiqRZ5Xrs2hgf0zHurCr0Tyhvi_hifNo03pHUvQKkQmgueazkrM88kP-lviryHb6XPn-_54_12Sy9BkluK_nwgHTi42byA-L5xgaZ5bR\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">CDavis@LifeSciAdvisors.com<\/a><\/p>\n<p>or<\/p>\n<p>Media:<\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2p4mKJOCl2CoweUGIZrYdPHacFCtn2VIRyd4EjT7qM4IZqqDWIyARlIWis98soTKE_ObBWgJcudyiDMiNwzKfFLmeYybpp4wJrAQXJ5vqxc=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">PR@vtvtherapeutics.com<\/a>\u00a0<\/p>\n<p>Source: vTv Therapeutics Inc.<\/p>\n<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTU5NyMzOTA3Mjc3IzIwMTk3OTU=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/acdfc064-d190-4775-a25e-e4cefb30336a\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>HIGH POINT, N.C., Jan. 06, 2021 (GLOBE NEWSWIRE) &#8212; vTv Therapeutics Inc.\u00a0(Nasdaq: VTVT) a clinical-stage biopharmaceutical company focused on the development of orally administered treatments for type 1 diabetes and inflammatory diseases, today announced that it is participating in the LifeSci Partners 10th Annual Healthcare Corporate Access Event held virtually from January 11-14 2021. Company management will be conducting one-on-one virtual meetings during the week of the conference concurrently with J.P. Morgan\u2019s 39th\u00a0Annual Healthcare Conference. To request a meeting, please visit the following registration link http:\/\/lifesci.events\/LifeSci2021. About\u00a0vTv Therapeutics vTv Therapeutics Inc.\u00a0is a clinical-stage biopharmaceutical company focused on developing oral small molecule drug candidates. vTv has a pipeline of clinical drug candidates led by programs for the treatment of type 1 &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vtv-therapeutics-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-virtually\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;vTv Therapeutics to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event Virtually&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-409924","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>vTv Therapeutics to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event Virtually - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vtv-therapeutics-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-virtually\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"vTv Therapeutics to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event Virtually - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"HIGH POINT, N.C., Jan. 06, 2021 (GLOBE NEWSWIRE) &#8212; vTv Therapeutics Inc.\u00a0(Nasdaq: VTVT) a clinical-stage biopharmaceutical company focused on the development of orally administered treatments for type 1 diabetes and inflammatory diseases, today announced that it is participating in the LifeSci Partners 10th Annual Healthcare Corporate Access Event held virtually from January 11-14 2021. Company management will be conducting one-on-one virtual meetings during the week of the conference concurrently with J.P. Morgan\u2019s 39th\u00a0Annual Healthcare Conference. To request a meeting, please visit the following registration link http:\/\/lifesci.events\/LifeSci2021. About\u00a0vTv Therapeutics vTv Therapeutics Inc.\u00a0is a clinical-stage biopharmaceutical company focused on developing oral small molecule drug candidates. vTv has a pipeline of clinical drug candidates led by programs for the treatment of type 1 &hellip; Continue reading &quot;vTv Therapeutics to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event Virtually&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/vtv-therapeutics-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-virtually\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-06T21:34:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTU5NyMzOTA3Mjc3IzIwMTk3OTU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vtv-therapeutics-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-virtually\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vtv-therapeutics-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-virtually\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"vTv Therapeutics to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event Virtually\",\"datePublished\":\"2021-01-06T21:34:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vtv-therapeutics-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-virtually\\\/\"},\"wordCount\":506,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vtv-therapeutics-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-virtually\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTU5NyMzOTA3Mjc3IzIwMTk3OTU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vtv-therapeutics-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-virtually\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vtv-therapeutics-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-virtually\\\/\",\"name\":\"vTv Therapeutics to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event Virtually - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vtv-therapeutics-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-virtually\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vtv-therapeutics-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-virtually\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTU5NyMzOTA3Mjc3IzIwMTk3OTU=\",\"datePublished\":\"2021-01-06T21:34:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vtv-therapeutics-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-virtually\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vtv-therapeutics-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-virtually\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vtv-therapeutics-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-virtually\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTU5NyMzOTA3Mjc3IzIwMTk3OTU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTU5NyMzOTA3Mjc3IzIwMTk3OTU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vtv-therapeutics-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-virtually\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"vTv Therapeutics to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event Virtually\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"vTv Therapeutics to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event Virtually - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/vtv-therapeutics-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-virtually\/","og_locale":"en_US","og_type":"article","og_title":"vTv Therapeutics to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event Virtually - Market Newsdesk","og_description":"HIGH POINT, N.C., Jan. 06, 2021 (GLOBE NEWSWIRE) &#8212; vTv Therapeutics Inc.\u00a0(Nasdaq: VTVT) a clinical-stage biopharmaceutical company focused on the development of orally administered treatments for type 1 diabetes and inflammatory diseases, today announced that it is participating in the LifeSci Partners 10th Annual Healthcare Corporate Access Event held virtually from January 11-14 2021. Company management will be conducting one-on-one virtual meetings during the week of the conference concurrently with J.P. Morgan\u2019s 39th\u00a0Annual Healthcare Conference. To request a meeting, please visit the following registration link http:\/\/lifesci.events\/LifeSci2021. About\u00a0vTv Therapeutics vTv Therapeutics Inc.\u00a0is a clinical-stage biopharmaceutical company focused on developing oral small molecule drug candidates. vTv has a pipeline of clinical drug candidates led by programs for the treatment of type 1 &hellip; Continue reading \"vTv Therapeutics to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event Virtually\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/vtv-therapeutics-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-virtually\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-06T21:34:19+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTU5NyMzOTA3Mjc3IzIwMTk3OTU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vtv-therapeutics-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-virtually\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vtv-therapeutics-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-virtually\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"vTv Therapeutics to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event Virtually","datePublished":"2021-01-06T21:34:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vtv-therapeutics-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-virtually\/"},"wordCount":506,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vtv-therapeutics-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-virtually\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTU5NyMzOTA3Mjc3IzIwMTk3OTU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vtv-therapeutics-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-virtually\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/vtv-therapeutics-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-virtually\/","name":"vTv Therapeutics to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event Virtually - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vtv-therapeutics-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-virtually\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vtv-therapeutics-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-virtually\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTU5NyMzOTA3Mjc3IzIwMTk3OTU=","datePublished":"2021-01-06T21:34:19+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vtv-therapeutics-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-virtually\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/vtv-therapeutics-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-virtually\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vtv-therapeutics-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-virtually\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTU5NyMzOTA3Mjc3IzIwMTk3OTU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTU5NyMzOTA3Mjc3IzIwMTk3OTU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vtv-therapeutics-to-participate-in-the-lifesci-partners-10th-annual-healthcare-corporate-access-event-virtually\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"vTv Therapeutics to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event Virtually"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/409924","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=409924"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/409924\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=409924"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=409924"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=409924"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}